Trials / Completed
CompletedNCT03789162
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 850 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
Detailed description
Participants will be 40 years of age or older, with a diagnosis of CRC, at any stage, confirmed with a tissue biopsy or a colorectal lesion at least 1 cm in size suspicious for adenoma (including sessile serrated adenoma) or CRC on a pre-enrollment colonoscopy, sigmoidoscopy, or computed tomography (CT) colonography. Approximately 1500 participants will be enrolled.
Conditions
Timeline
- Start date
- 2018-12-20
- Primary completion
- 2025-03-31
- Completion
- 2025-05-29
- First posted
- 2018-12-28
- Last updated
- 2025-06-29
Locations
45 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT03789162. Inclusion in this directory is not an endorsement.